MENU
HLUBF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

H. Lundbeck A/S (HLUBF) Ownership - Who owns H. Lundbeck A/S?

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products... Show more

Profile

Industry
N/A
Address
Ottiliavej 9
Phone
+45 36301311
Employees
5681
Web
https://www.lundbeck.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
6.17B
P/E Ratio
9.04
Total Cash
2.65B
Projected Growth
5.97
Total Debt
13.65B
Revenue
23.52B
Risk (Beta)
0.02
Dividend Yield
0.03
Total Cash/Share
2.67
Total Debt/Equity
N/A
Revenue/Share
3.71 USD as % of share price

Fundamentals

HLUBF
Capitalization
6.18B
P/E Ratio
9.04
Risk (Beta)
0.02
Dividend Yield
0.03
Total Cash
2.65B
Total Cash/Share
2.67
Total Debt
13.6B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
5.97
Revenue/Share (as % of the share price)
3.71%
Revenue
23.5B
ROE
N/A
Book Value
24.2B
P/B Ratio
1.30
Cash Flow
N/A
Earnings
3.52
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
996M
Current Ratio
1.59
Current Revenue Per Employee
1056666.60
Dividends Per Share - Security
0.00
EBITDA
4.82B
Float
N/A
Float - Current
N/A
Gross Income Margin
81.89
Revenue To Assets
7.67
Shares Held By Institutions
128M
Shares Outstanding - Current
992M
Total Liabilities
27.6B
Total Volume MTD
N/A
Value
1
Gain YTD
12.190
View a ticker or compare two or three
HLUBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Ottiliavej 9
Phone
+45 36301311
Employees
5681
Web
https://www.lundbeck.com